Xuefeng Yu, CanSino Biologics CEO (Imaginechina via AP Images)

Covid-19 roundup: CanSi­no’s in­haled vac­cine gets thumbs-up from Chi­nese reg­u­la­tors; Sino­vac gets go-ahead for boost­er tri­al in Chile

While the world has been fo­cused on in­jectable boost­er shots to ad­dress the Omi­cron vari­ant, one com­pa­ny fo­cused on a dif­fer­ent ap­proach has seen its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.